Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-14 Sale |
2024-06-18 4:05 pm |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
17,172 | $35.42 | $608,315 | 91,757 (Direct) |
View |
| 2024-05-30 Sale |
2024-06-03 4:05 pm |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
35,000 | $34.05 | $1,191,775 | 105,728 (Direct) |
View |
| 2022-08-11 Sale |
2022-08-15 4:16 pm |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
20,000 | $36.52 | $730,485 | 45,406 (Direct) |
View |
| 2021-12-23 Sale |
2021-12-28 4:02 pm |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
9,500 | $42 | $399,000 | 58,329 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-17 4:02 pm |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
9,500 | $43.57 | $413,883 | 67,829 (Direct) |
View |
| 2021-08-10 Sale |
2021-08-12 10:00 am |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
2,738 | $45.25 | $123,895 | 77,329 (Direct) |
View |
| 2020-06-09 Purchase |
2020-06-10 07:55 am |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
9,750 | $3.05 | $29,738 | 10,735 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-14 Exercise |
2024-06-18 4:05 pm |
N/A 2028-06-13 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
20,169 | $0 | 91,757 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 4:05 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
3,201 | $9.0165 | 91,757 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 4:05 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
16,968 | $10.38 | 91,757 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:13 pm |
2025-06-13 2034-06-13 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
81,000 | $0 | 81,000 (Direct) |
View |
| 2024-05-30 Exercise |
2024-06-03 4:05 pm |
N/A 2030-06-18 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
25,000 | $0 | 105,728 (Direct) |
View |
| 2024-05-30 Exercise |
2024-06-03 4:05 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
25,000 | $10.38 | 105,728 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-04 4:05 pm |
N/A 2029-06-19 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
10,750 | $0 | 35,128 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-04 4:05 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
10,750 | $2.78 | 35,128 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:17 pm |
2024-06-15 2033-06-15 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-15 4:16 pm |
N/A 2028-06-13 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
20,000 | $0 | 45,406 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-15 4:16 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
6,329 | $9.0165 | 45,406 (Direct) |
View |
| 2022-08-12 Exercise |
2022-08-15 4:16 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
13,671 | $2.78 | 45,406 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 4:13 pm |
2023-06-16 2032-06-16 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP AND CFO |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-28 4:02 pm |
N/A 2028-06-13 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
7,000 | $0 | 58,329 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-28 4:02 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
3,250 | $9.0165 | 58,329 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-28 4:02 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
3,750 | $2.78 | 58,329 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 4:02 pm |
N/A 2028-06-13 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
7,000 | $0 | 67,829 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 4:02 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
3,250 | $9.0165 | 67,829 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 4:02 pm |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
3,750 | $2.78 | 67,829 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-12 10:00 am |
N/A 2028-06-13 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
21,381 | $0 | 77,329 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-12 10:00 am |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
10,302 | $9.0165 | 77,329 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-12 10:00 am |
N/A N/A |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
11,079 | $2.78 | 77,329 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:26 pm |
2022-06-17 2031-06-17 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
85,000 | $0 | 85,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 08:07 am |
2021-06-18 2030-06-18 |
Celldex Therapeutics Inc. | CLDX | Martin Samuel Bates SVP and CFO |
105,600 | $0 | 105,600 (Direct) |
View |